EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Riboflavin and Its Derivates as Potential Photosensitizers in the Photodynamic Treatment of Skin Cancers

Małgorzata Insińska-Rak, Marek Sikorski iD, Agnieszka Wolnicka-Glubisz iD

Cells · 19.09.2023 · 12 (18) · 2304

DOI: 10.3390/cells12182304 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.09.2023. Verfasst von Małgorzata Insińska-Rak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 8, 61-614 Poznań, Poland. Hauptthemen laut MEDLINE: Photochemotherapy, Skin Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Riboflavin, a water-soluble vitamin B2, possesses unique biological and physicochemical properties. Its photosensitizing properties make it suitable for various biological applications, such as pathogen inactivation and photodynamic therapy. However, the effectiveness of riboflavin as a photosensitizer is hindered by its degradation upon exposure to light. The review aims to highlight the significance of riboflavin and its derivatives as potential photosensitizers for use in photodynamic therapy. Additionally, a concise overview of photodynamic therapy and utilization of blue light in dermatology is provided, as well as the photochemistry and photobiophysics of riboflavin and its derivatives. Particular emphasis is given to the latest findings on the use of acetylated 3-methyltetraacetyl-riboflavin derivative (3MeTARF) in photodynamic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapySkin NeoplasmsHumansPhotosensitizing AgentsRiboflavinVitamins

Stichwörter der Autor:innen

3MeTARFPDTlumichromemelanomariboflavinsinglet oxygenskin cancer

Substanzen

Photosensitizing AgentsRiboflavinVitamins

Autor:innen und Institutionen

  • Faculty of Chemistry, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 8, 61-614 Poznań, Poland.
  • Department of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.

ORCID-Profile: Marek Sikorski, Agnieszka Wolnicka-Glubisz

Förderung

  • National Science Centre, Poland

Zitieren

APA

Insińska-Rak, M., Sikorski, M., & Wolnicka-Glubisz, A. (2023). Riboflavin and Its Derivates as Potential Photosensitizers in the Photodynamic Treatment of Skin Cancers. Cells, 12(18), 2304. https://doi.org/10.3390/cells12182304

Vancouver

Insińska-Rak M, Sikorski M, Wolnicka-Glubisz A. Riboflavin and Its Derivates as Potential Photosensitizers in the Photodynamic Treatment of Skin Cancers. Cells. 2023;12(18):2304. doi:10.3390/cells12182304

BibTeX
@article{InsiskaRak2023,
  author = {Insińska-Rak, Małgorzata and Sikorski, Marek and Wolnicka-Glubisz, Agnieszka},
  title = {Riboflavin and Its Derivates as Potential Photosensitizers in the Photodynamic Treatment of Skin Cancers},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {2304},
  doi = {10.3390/cells12182304}
}
Kostenlos starten →